CTRI/2022/01/039856Active, not recruitingPhase 2
Preclinical and clinical evaluation of the effect on oral administration of MEDATHAARI CHOORANAM along with external application of CHITHIRAMOOLA TAILAM in the management of BALAR KEELVAYU.
Dr P Ponsridharani0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 2
- Status
- Active, not recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •2.Pain and swelling of the joints
- •3.Morning stiffness
- •4.Rheumatoid factor positive or negative
Exclusion Criteria
- •1.Children above 12 years
- •2.Children below 5 years
- •3.Rheumatic fever
- •4.Psoriatic arthritis
- •5.Gouty arthritis
- •6. Neurological disorders
Investigators
Similar Trials
Not yet recruiting
Phase 2
Preclinical and Clinical evaluation of the effect on oral administration of PARANGI KASAYAM along with external application of VARMAM THERAPHY in the management of INFANTILE HEMIPLEGIA in childreCTRI/2022/11/046972DR M MUKILA
Completed
Phase 2
Preclinical and clinical evaluation of Siddha classical drug KARUNJEERAKA MATHIRAI (oral administration)along with application of NUNAA TAILAM(external) in the management of VITILIGO in childreCTRI/2022/01/039863Dr S Surendar
Completed
Phase 2
Preclinical and clinical evaluation of the effect of siddha classical drug MANITHAKKALI ENNAI (oral administration) in the management of VITAMIN -B COMPLEX DEFICIENCYCTRI/2022/02/039956Dr S Aiswarya40
Completed
Phase 2
Preclinical and clinical evaluation of the effect of Siddha classical drug GANTHAGA NEI(oral administration) along with NATHTHAICHOORI TAILAM(external therapy) in the management of CEREBRAL PALSY.CTRI/2022/06/043082Dr P RAJAVATHANA40
Completed
Phase 2
Preclinical and clinical evaluation of the effect of Siddha classical drug PARUMA NOI NIVARANA MAATHIRAI & NEERMULLI OORAL KUDINEER (oral administration ) along with PODI THIMIRTHAL ( external therapy) in the management of CHILDHOOD OBESITY.CTRI/2022/02/040297Dr J Mangalavalli40
